Case Report, J Regen Med Vol: 4 Issue: 1
A Decade after Foetal Skin Progenitor Cell Therapy in Pediatric Burn Treatment
| Anthony de Buys Roessingh2, Nathalie Hirt-Burri1, Wassim Raffoul1, Corinne Scaletta1 and Lee Ann Applegate1* | |
| 1Plastic, Reconstructive and Hand Surgery, Unit of Regenerative Therapy, University Hospital of Lausanne, CHUV/UNIL, EPCR 02, 1066 Epalinges, Switzerland | |
| 2Department of Pediatric Surgery, University Hospital of Lausanne, CHUV/ UNIL, BH 10, 1011 Lausanne, Switzerland | |
| Corresponding author : Prof. Lee Ann Laurent-Applegate Regenerative Therapy Unit, Department of Musculoskeletal Medicine, Plastic, Reconstructive and Hand Surgery, University Hospital of Lausanne-CHUV, EPCR 02/ch. Croisettes 22, 1066 Epalinges, Switzerland Tel: +41 21 887 70 42; Fax: +41 21 887 84 14 E-mail: Lee.Laurent-Applegate@chuv.ch |
|
| Received: May 11, 2015 Accepted: August 24, 2015 Published: August 29, 2015 | |
| Citation: Roessingh AdeB, Hirt-Burri N, Raffoul W, Scaletta C, Applegate LA (2015) A Decade after Foetal Skin Progenitor Cell Therapy in Pediatric Burn Treatment. J Regen Med 4:1. doi:10.4172/2325-9620.1000122 |
Abstract
A decade ago, a study was reported on the management of pediatric burns using cell therapy and foetal skin progenitor cells. We now present follow-up on the patients in that original clinical study. We describe the regulatory requirements for clinical research, specifically that research conducted in a hospital environment and involving human cell and tissue based products. Also, how these requirements have changed since 2007 and how these changes might adversely affect burn victims and their Clinical Care Pathways in the future will be addressed in this report.
